Real-time enrollment status for this attention deficit disorder with hyperactivity (adhd) clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:08 PM UTC
| NCT Number | NCT07755410 |
| Recruiting Status | Recruiting |
| Condition | Attention Deficit Disorder With Hyperactivity (ADHD) |
| Phase | PHASE2 |
| Target Enrollment | 312 participants |
| Active Locations | 19 sites in the US |
| Sponsor | Alkermes, Inc. |
| Last Updated on CT.gov | October 7, 2026 (2 weeks ago) |
As of October 21, 2026: Clinical trial NCT07755410 is currently recruiting participants. This phase2 study for attention deficit disorder with hyperactivity (adhd) is actively seeking new participants at 19 locations across the United States. The study is sponsored by Alkermes, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07755410 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07755410 was last updated 2 weeks ago (October 7, 2026). HelloStudys verifies this status automatically.